Aldosterone in Chronic Kidney and Cardiac Disease
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Eberhard Ritz Regulatory systems, which are normally involved in homeostasis, can take on maladaptive roles. This paradoxical situation has been convincingly demonstrated in heart failure. The evidence is strongest with respect to the beneficial effects of sympathetic and renin-angiotensin-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · cited 1×
“The first large clinical trial testing the efficacy of spironolactone in heart failure was reported in 1999 (20).”
BackgroundThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394 · cited 1×
“The effects of ACE inhibition on the course of clinical renal insufficiency have been generally beneficial, as previously noted (5,7,41).”
BackgroundPitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Nongenomic actions of steroid hormones
Lösel, R., & Wehling, M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1009 · Cited by 980
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910 · cited 1×
“The effects of ACE inhibition on the course of clinical renal insufficiency have been generally beneficial, as previously noted (5,7,41).”
BackgroundEffectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466 · cited 1×
“(50) identified 13 patients with type II diabetes mellitus who were treated with an ACE inhibitor but whose aldosterone levels increased after initial suppression (i.”
Background
Cited by
Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system
Palmer, B. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035279 · Cited by 640
Role of Diminished Renal Function in Cardiovascular Mortality
Schrier, R. W. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.067 · Cited by 403
Navaneethan, S. D., Nigwekar, S. U., Sehgal, A. R., & Strippoli, G. F. M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04750908 · Cited by 258
Bauersachs, J., Jaisser, F., & Toto, R. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04488 · Cited by 257
Chung, E. Y., Ruospo, M., Natale, P., Bolignano, D., Navaneethan, S. D., Palmer, S. C., & Strippoli, G. F. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004.pub4 · Cited by 157
Metadata
- Authors
- Hostetter, T. H., & Ibrahim, H. N.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2003-09
- Volume
- 14
- Issue
- 9
- Pages
- 2395-2401
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2145584016
- Cited by
- 137
- References
- 7
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aldosterone in Chronic Kidney and Cardiac Disease. https://app.cochat.ai/papers/10.1097/01.asn.0000086472.65806.73
- The paper
- Hostetter, T. H., & Ibrahim, H. N. (2003). Aldosterone in Chronic Kidney and Cardiac Disease. Journal of the American Society of Nephrology. https://doi.org/10.1097/01.asn.0000086472.65806.73
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.